Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C.

Nervenarzt. 2019 Sep;90(9):958-960. doi: 10.1007/s00115-019-0766-7. German. No abstract available.

PMID:
31309271
2.

The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?

Hommers L, Fischer M, Reif-Leonhard C, Pfuhlmann B, Deckert J, Unterecker S.

Clin Drug Investig. 2019 May;39(5):485-489. doi: 10.1007/s40261-019-00768-7.

PMID:
30805791
3.

[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C.

Nervenarzt. 2019 May;90(5):463-471. doi: 10.1007/s00115-018-0643-9. Review. German. Erratum in: Nervenarzt. 2019 Jul 15;:.

PMID:
30446893
4.

Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine.

Hommers L, Scharl M, Hefner G, Hohner M, Fischer M, Pfuhlmann B, Deckert J, Unterecker S.

J Clin Psychopharmacol. 2018 Jun;38(3):188-192. doi: 10.1097/JCP.0000000000000877.

PMID:
29620699
5.

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>.

Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C.

World J Biol Psychiatry. 2018 Apr;19(3):162-174. doi: 10.1080/15622975.2018.1439595. Epub 2018 Mar 1. Review.

PMID:
29493375
6.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P.

Pharmacopsychiatry. 2018 Jan;51(1-02):e1. doi: 10.1055/s-0037-1600991. Epub 2018 Feb 1. No abstract available.

PMID:
29390205
7.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P.

Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14. Review. Erratum in: Pharmacopsychiatry. 2018 Jan;51(1-02):e1.

8.

The role of Pannexin gene variants in schizophrenia: systematic analysis of phenotypes.

Gawlik M, Wagner M, Pfuhlmann B, Stöber G.

Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):433-7. doi: 10.1007/s00406-015-0619-8. Epub 2015 Jul 30.

PMID:
26223428
9.

Increase of Heart Rate and QTc by Amitriptyline, But Not by Venlafaxine, Is Correlated to Serum Concentration.

Unterecker S, Pfuhlmann B, Kopf J, Kittel-Schneider S, Reif A, Deckert J.

J Clin Psychopharmacol. 2015 Aug;35(4):460-3. doi: 10.1097/JCP.0000000000000336.

PMID:
26035054
10.

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.

Proft F, Kopf J, Olmes D, Hempel S, Schmidt B, Riederer P, Deckert J, Pfuhlmann B, Reif A, Unterecker S.

Pharmacopsychiatry. 2015 Mar;48(2):81. doi: 10.1055/s-0035-1545318. Epub 2015 Mar 4. No abstract available.

PMID:
25738265
11.

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.

Proft F, Kopf J, Olmes D, Hempel S, Schmidt B, Riederer P, Deckert J, Pfuhlmann B, Reif A, Unterecker S.

Pharmacopsychiatry. 2014 Nov;47(7):245-50. doi: 10.1055/s-0034-1390412. Epub 2014 Oct 8. Erratum in: Pharmacopsychiatry. 2015 Mar;48(2):81.

PMID:
25295552
12.

How to adjust media recommendations on reporting suicidal behavior to new media developments.

Maloney J, Pfuhlmann B, Arensman E, Coffey C, Gusmão R, Poštuvan V, Scheerder G, Sisask M, van der Feltz-Cornelis CM, Hegerl U, Schmidtke A.

Arch Suicide Res. 2014;18(2):156-69. doi: 10.1080/13811118.2013.824833.

PMID:
24627947
13.

Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.

Unterecker S, Reif A, Hempel S, Proft F, Riederer P, Deckert J, Pfuhlmann B.

Int Clin Psychopharmacol. 2014 Jul;29(4):206-11. doi: 10.1097/YIC.0000000000000025.

14.

The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.

Unterecker S, Proft F, Riederer P, Lauer M, Deckert J, Pfuhlmann B.

Ther Drug Monit. 2014 Apr;36(2):269-72. doi: 10.1097/FTD.0000000000000008.

PMID:
24365982
15.

[Differences between patients in consultation psychiatry and psychiatric inpatients].

Unterecker S, Maloney J, Pfuhlmann B, Deckert J, Warrings B.

Psychiatr Prax. 2014 May;41(4):221-3. doi: 10.1055/s-0033-1349556. Epub 2013 Sep 23. German.

PMID:
24062152
16.

Interaction of valproic acid and amitriptyline: analysis of therapeutic drug monitoring data under naturalistic conditions.

Unterecker S, Burger R, Hohage A, Deckert J, Pfuhlmann B.

J Clin Psychopharmacol. 2013 Aug;33(4):561-4. doi: 10.1097/JCP.0b013e3182905d42.

PMID:
23775047
17.

Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study.

Schneider S, Bahmer TJ, Metzger FG, Reif A, Polak T, Pfuhlmann B, Walter G, Eberle MC, Ernst LH, Fallgatter AJ, Ehlis AC.

Int J Neuropsychopharmacol. 2013 Oct;16(9):1911-25. doi: 10.1017/S1461145713000540. Epub 2013 Jun 12.

18.

Media recommendations on reporting suicidal behaviour and suggestions for optimisation.

Maloney J, Pfuhlmann B, Arensman E, Coffey C, Gusmão R, Poštuvan V, Scheerder G, Sisask M, van der Feltz-Cornelis CM, Hegerl U, Schmidtke A.

Acta Psychiatr Scand. 2013 Oct;128(4):314-5. doi: 10.1111/acps.12131. Epub 2013 Apr 17. No abstract available.

PMID:
23590817
19.

Serious suicidal behaviors: socio-demographic and clinical features in a multinational, multicenter sample.

Carli V, Mandelli L, Zaninotto L, Iosue M, Hadlaczky G, Wasserman D, Hegerl U, Värnik A, Reisch T, Pfuhlmann B, Maloney J, Schmidtke A, Serretti A, Sarchiapone M.

Nord J Psychiatry. 2014 Jan;68(1):44-52. doi: 10.3109/08039488.2013.767934. Epub 2013 Feb 19.

PMID:
23421730
20.

Elevated clozapine serum levels in combination with perazine.

Fischer M, Unterecker S, Deckert J, Pfuhlmann B.

Psychopharmacology (Berl). 2013 Apr;226(3):623-5. doi: 10.1007/s00213-013-3007-y. Epub 2013 Feb 9. No abstract available.

PMID:
23397051
21.

The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic study.

Taurines R, Burger R, Wewetzer C, Pfuhlmann B, Mehler-Wex C, Gerlach M, Egberts K.

Ther Drug Monit. 2013 Feb;35(1):84-91. doi: 10.1097/FTD.0b013e31827a1aad. Erratum in: Ther Drug Monit. 2018 Jun;40(3):381.

PMID:
23318280
22.

Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions.

Unterecker S, Riederer P, Proft F, Maloney J, Deckert J, Pfuhlmann B.

J Neural Transm (Vienna). 2013 Aug;120(8):1237-46. doi: 10.1007/s00702-012-0952-2. Epub 2012 Dec 20.

PMID:
23254926
23.

Interactions and monitoring of antipsychotic drugs.

Hiemke C, Pfuhlmann B.

Handb Exp Pharmacol. 2012;(212):241-65. doi: 10.1007/978-3-642-25761-2_10. Review.

PMID:
23129335
24.

Therapeutic drug monitoring of antidepressants in haemodialysis patients.

Unterecker S, Müller P, Jacob C, Riederer P, Pfuhlmann B.

Clin Drug Investig. 2012 Aug 1;32(8):539-45. doi: 10.2165/11633560-000000000-00000.

PMID:
22715858
25.

Therapeutic drug monitoring for antidepressant drug treatment.

Ostad Haji E, Hiemke C, Pfuhlmann B.

Curr Pharm Des. 2012;18(36):5818-27.

PMID:
22681162
26.

The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions.

Unterecker S, Hiemke C, Greiner C, Haen E, Jabs B, Deckert J, Pfuhlmann B.

Pharmacopsychiatry. 2012 Sep;45(6):229-35. doi: 10.1055/s-0031-1301366. Epub 2012 Mar 16.

PMID:
22426847
27.

Evaluation of conserved and ultra-conserved non-genic sequences in chromosome 15q15-linked periodic catatonia.

Schanze D, Ekici AB, Pfuhlmann B, Reis A, Stöber G.

Am J Med Genet B Neuropsychiatr Genet. 2012 Jan;159B(1):77-86. doi: 10.1002/ajmg.b.32004. Epub 2011 Dec 7.

PMID:
22162401
28.

No influence of body weight on serum levels of antidepressants.

Unterecker S, Deckert J, Pfuhlmann B.

Ther Drug Monit. 2011 Dec;33(6):730-4. doi: 10.1097/FTD.0b013e318237b0fa.

PMID:
22105590
29.

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G.

Pharmacopsychiatry. 2011 Sep;44(6):195-235. Review.

PMID:
22053351
30.

Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report.

Unterecker S, Warrings B, Deckert J, Pfuhlmann B.

Pharmacopsychiatry. 2012 Jan;45(1):30-4. doi: 10.1055/s-0031-1286346. Epub 2011 Oct 12.

PMID:
21993870
31.

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G.

Pharmacopsychiatry. 2011 Sep;44(6):195-235. doi: 10.1055/s-0031-1286287. Epub 2011 Sep 27.

PMID:
21969060
32.

Is Ankyrin a genetic risk factor for psychiatric phenotypes?

Gella A, Segura M, Durany N, Pfuhlmann B, Stöber G, Gawlik M.

BMC Psychiatry. 2011 Jun 24;11:103. doi: 10.1186/1471-244X-11-103.

33.

Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study.

Ehlis AC, Pauli P, Herrmann MJ, Plichta MM, Zielasek J, Pfuhlmann B, Stöber G, Ringel T, Jabs B, Fallgatter AJ.

World J Biol Psychiatry. 2012 Mar;13(3):188-99. doi: 10.3109/15622975.2011.566354. Epub 2011 Apr 26. Erratum in: World J Biol Psychiatry. 2012 Jul;13(5):400.

PMID:
21517702
34.

Case report: intoxication with high dose of long-acting methylphenidate (Concerta(®)) in a suicidal 14-year-old girl.

Klampfl K, Quattländer A, Burger R, Pfuhlmann B, Warnke A, Gerlach M.

Atten Defic Hyperact Disord. 2010 Dec;2(4):221-4. doi: 10.1007/s12402-010-0032-0. Epub 2010 Sep 14.

PMID:
21432608
35.

Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.

Schanze D, Ekici AB, Gawlik M, Pfuhlmann B, Reis A, Stöber G.

Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):198-203. doi: 10.1002/ajmg.b.31156. Epub 2011 Jan 13.

PMID:
21302348
36.

["My disease is one of the mind and difficult to define": Robert Walser (1879-1956) and his mental illness].

Partl S, Pfuhlmann B, Jabs B, Stöber G.

Nervenarzt. 2011 Jan;82(1):67-78. doi: 10.1007/s00115-009-2914-y. German.

PMID:
21274695
37.

False-positive methadone drug screens during quetiapine treatment.

Fischer M, Reif A, Polak T, Pfuhlmann B, Fallgatter AJ.

J Clin Psychiatry. 2010 Dec;71(12):1696. doi: 10.4088/JCP.10l06044yel. No abstract available.

PMID:
21190642
38.

The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach.

Gawlik M, Wehner I, Mende M, Jung S, Pfuhlmann B, Knapp M, Stöber G.

BMC Psychiatry. 2010 Jul 29;10:59. doi: 10.1186/1471-244X-10-59.

39.

Serum concentrations of paliperidone versus risperidone and clinical effects.

Nazirizadeh Y, Vogel F, Bader W, Haen E, Pfuhlmann B, Gründer G, Paulzen M, Schwarz M, Zernig G, Hiemke C.

Eur J Clin Pharmacol. 2010 Aug;66(8):797-803. doi: 10.1007/s00228-010-0812-7. Epub 2010 Apr 1.

PMID:
20358189
40.

Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.

Klampfl K, Taurines R, Preuss A, Burger R, Rothenhöfer S, Wewetzer Ch, Pfuhlmann B, Fegert J, Gerlach M, Mehler-Wex C.

Pharmacopsychiatry. 2010 Mar;43(2):58-65. doi: 10.1055/s-0029-1239540. Epub 2009 Dec 10.

PMID:
20336598
41.

Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.

Waldschmitt C, Vogel F, Pfuhlmann B, Hiemke C.

Pharmacopsychiatry. 2009 Sep;42(5):189-93. doi: 10.1055/s-0029-1220890. Epub 2009 Sep 1.

PMID:
19724981
42.

Toxic clozapine serum levels during inflammatory reactions.

Pfuhlmann B, Hiemke C, Unterecker S, Burger R, Schmidtke A, Riederer P, Deckert J, Jabs B.

J Clin Psychopharmacol. 2009 Aug;29(4):392-4. doi: 10.1097/JCP.0b013e3181acd20b. No abstract available.

PMID:
19593184
43.

The influence of smoking on the serum level of duloxetine.

Fric M, Pfuhlmann B, Laux G, Riederer P, Distler G, Artmann S, Wohlschläger M, Liebmann M, Deckert J.

Pharmacopsychiatry. 2008 Jul;41(4):151-5. doi: 10.1055/s-2008-1073173.

PMID:
18651344
44.

Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.

Pfuhlmann B, Gerlach M, Burger R, Gonska S, Unterecker S, Jabs B, Riederer P, Deckert J.

J Neural Transm Suppl. 2007;(72):287-96.

PMID:
17982905
45.

[Folie à deux - mental infection or individual psychosis].

Jabs B, Jabs K, Reif A, Pfuhlmann B.

Fortschr Neurol Psychiatr. 2008 Mar;76(3):149-54. Epub 2007 Sep 26. Review. German.

PMID:
17899493
46.

Improvement of prefrontal brain function in endogenous psychoses under atypical antipsychotic treatment.

Ehlis AC, Herrmann MJ, Pauli P, Stoeber G, Pfuhlmann B, Fallgatter AJ.

Neuropsychopharmacology. 2007 Aug;32(8):1669-77. Epub 2007 Jan 3.

47.

Family-based study of markers at the 5'-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses.

Stöber G, Sprandel J, Jabs B, Pfuhlmann B, Möller-Ehrlich K, Knapp M.

Eur Arch Psychiatry Clin Neurosci. 2006 Oct;256(7):422-7. Epub 2006 Jun 16.

PMID:
16783497
48.

[Cycloid psychoses as atypical manic-depressive disorders. Results of a family study].

Jabs B, Althaus G, Bartsch A, Schmidtke A, Stöber G, Beckmann H, Pfuhlmann B.

Nervenarzt. 2006 Sep;77(9):1096-100, 1102-4. German.

PMID:
16502008
49.

ZDHHC8 as a candidate gene for schizophrenia: analysis of a putative functional intronic marker in case-control and family-based association studies.

Faul T, Gawlik M, Bauer M, Jung S, Pfuhlmann B, Jabs B, Knapp M, Stöber G.

BMC Psychiatry. 2005 Oct 14;5:35.

50.

Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses.

Reif A, Pfuhlmann B, Lesch KP.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1162-8.

PMID:
16055253

Supplemental Content

Loading ...
Support Center